Adaptive Biotechnologies (ADPT) shareholders back directors, pay and 2026 auditor
Rhea-AI Filing Summary
Adaptive Biotechnologies Corporation reported the results of its annual shareholder meeting held on June 5, 2026. Shareholders voted on electing two Class I directors, an advisory say-on-pay proposal, and ratifying the independent auditor.
Robert Hershberg received 93,188,652 votes for, or 71.81% of votes on the proposal, with 36,573,708 votes withheld and 13,570,859 broker non-votes. Katey Owen received 126,803,695 votes for, or 97.72%, with 2,958,666 votes withheld and the same broker non-votes.
The advisory vote on 2025 named executive officer compensation passed with 125,287,618 votes for (96.55%), 4,316,144 against, and 158,599 abstentions, plus 13,570,859 broker non-votes. Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026 passed with 142,609,643 votes for (99.50%), 484,798 against, and 238,779 abstentions.
Positive
- None.
Negative
- None.